Valuation: cbdMD, Inc.

Market Cap 5.98M 5.23M 4.82M 4.45M 8.38M 576M 8.57M 57.67M 22.68M 282M 22.47M 21.98M 971M P/E 2026 *
-3x
P/E 2027 * -8.14x
Enterprise Value 5.98M 5.23M 4.82M 4.45M 8.38M 576M 8.57M 57.67M 22.68M 282M 22.47M 21.98M 971M EV / Sales 2026 *
0.27x
EV / Sales 2027 * 0.26x
Free-Float
89.32%
Yield 2026 *
-
Yield 2027 * -
1 day-7.63%
1 week-27.61%
Current month-15.32%
1 month-20.85%
3 months-27.86%
6 months-38.26%
Current year-57.79%
1 week 0.56
Extreme 0.5602
0.82
1 month 0.56
Extreme 0.5602
0.82
Current year 0.56
Extreme 0.5602
1.34
1 year 0.47
Extreme 0.4701
2.56
3 years 0.47
Extreme 0.4701
13.84
5 years 0.47
Extreme 0.4701
1,000.8
10 years 0.47
Extreme 0.4701
2,606.4
Manager TitleAgeSince
Chief Executive Officer 47 01/03/2023
Chief Tech/Sci/R&D Officer - 01/01/2019
Chief Tech/Sci/R&D Officer 45 -
Director TitleAgeSince
Director/Board Member 66 10/04/2025
Director/Board Member 47 18/12/2024
Director/Board Member 41 01/03/2017
Date Insider Type Main position Quantity % Market Cap.
4/14/26 A Free

Chief Technology Officer

1,572 0.0150%
4/14/26 A Free

Director

1,572 0.0150%
4/14/26 A Free

Director

1,572 0.0150%
Change 5-day change 1-year change 3-year change Capi.($)
-7.63%-27.61%-41.00%-95.02% 5.98M
+0.85%-0.80%+52.79%+161.33% 1,051B
+1.23%-1.53%+54.58%+59.08% 609B
+0.04%+2.58%+34.47%+86.33% 450B
+0.78%-0.71%+29.28%+24.10% 330B
+1.41%+0.58%+35.44%+40.67% 284B
-0.27%-1.87%+22.34%+22.51% 263B
-1.76%+2.37%-20.43%-38.00% 223B
-1.42%+0.80%+24.27%+57.50% 198B
-1.48%+3.43%+24.08%+71.67% 167B
Average -0.82%-2.28%+21.58%+39.02% 357.51B
Weighted average by Cap. +0.37%+0.02%+37.51%+79.63%

Financials

2026 *2027 *
Net sales 22.15M 19.36M 17.86M 16.47M 31.04M 2.13B 31.73M 214M 83.98M 1.04B 83.2M 81.37M 3.6B 23.26M 20.33M 18.76M 17.29M 32.59M 2.24B 33.31M 224M 88.18M 1.1B 87.36M 85.44M 3.78B
Net income -1.9M -1.66M -1.53M -1.41M -2.66M -183M -2.72M -18.33M -7.21M -89.71M -7.14M -6.99M -309M -902K -788K -727K -670K -1.26M -86.86M -1.29M -8.69M -3.42M -42.54M -3.39M -3.31M -146M
Net Debt - -
Logo cbdMD, Inc.
cbdMD, Inc. is a consumer wellness company focused on the development, manufacturing, marketing, and sale of supplement brands powered by natural compounds. Its hemp-derived cannabinoids, include full-spectrum cannabidiol (CBD) formulations, hemp-derived Delta-9 THC products and a range of functional products designed to address key wellness needs, such as sleep, recovery, mood, discomfort, mobility, cognitive function, and stress management. It operates a multi-brand portfolio anchored by its flagship cbdMD line, which offers oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. Its Paw CBD pet-wellness brand provides tinctures, chews, and topicals for dogs and cats. Its ATRX platform offers non-cannabinoid functional ingredients such as functional mushrooms. Its Herbal Oasis (Oasis) brand is a premium hemp-derived THC-infused social seltzer that blends cannabinoids and nootropic mushrooms.
Employees
42
Date Price Change Volume
17/07/26 $0.5699 -7.63% 231,770
16/07/26 $0.6170 -3.59% 549,798
15/07/26 $0.6400 -2.69% 290,841
14/07/26 $0.6577 -3.56% 196,903
13/07/26 $0.6820 -13.37% 920,046
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.5699USD
Average target price
2.000USD
Spread / Average Target
+250.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. YCBD Stock